康惠制药拟变更证券简称为康惠股份

Core Viewpoint - Kanghui Pharmaceutical (603139) announced a change in its stock name from "Kanghui Pharmaceutical" to "Kanghui Co., Ltd." to align with its long-term development plan, aiming for clearer market understanding and better reflection of its core value and development direction [1] Summary by Relevant Sections - Company Name Change - The new stock name is intended to be more concise and clear, retaining the core brand "Kanghui" while adding "Co., Ltd." to enhance market comprehension [1] - Impact on Business Operations - The company stated that this name change will not have a significant impact on its current operating performance, and there are no major changes in its main business [1] - Regulatory Compliance - The name change complies with relevant laws and regulations, including the Company Law and Securities Law, as well as the company's articles of association [1]